Records containing: Stage IVB Lung Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-15A Phase II/III Study of N-803 (ALT-803) Plus Pembrolizumab Versus Standard of Care in Participants With Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated With Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)
-
CLINICAL_TRIALS study record update · 2025-05-06Phase II Clinical Trial Evaluating Intravenous AZD9150 (Antisense STAT3) With MEDI4736 (Anti-PD-L1) in Patients With Advanced Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2025-04-29Using Genetics and Shared Decision Making to Improve Lung Cancer Care: A Developmental Study
-
CLINICAL_TRIALS study record update · 2025-02-07Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related Fatigue
-
CLINICAL_TRIALS study record update · 2025-01-27Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-27Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated With First-Line MK-3475 (Pembrolizumab)+/- Chemotherapy (Oncologist's/Patient's Choice)
-
CLINICAL_TRIALS study record update · 2025-01-14A Phase I Trial of Intratumoral Administration of CCL21-Gene Modified Dendritic Cell (Ad-CCL21-DC) Combined With Intravenous Pembrolizumab for Advanced NSCLC
-
CLINICAL_TRIALS study record update · 2024-07-09A Randomized Phase II Study of Carboplatin and Pemetrexed w/ or w/o Selpercatinib in Participants With Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer and Progression of Disease on Prior RET Directed Therapy (Lung-MAP Sub-Study)
-
CLINICAL_TRIALS study record update · 2024-05-24Novel Dynamic PET Kinetics and MRI Radiomics Analyses in Brain Tumors
-
CLINICAL_TRIALS study record update · 2024-03-22A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2024-01-05Family Caregivers in Underserved Populations Providing Complex Cancer Care
-
CLINICAL_TRIALS study record update · 2023-12-15A Phase 2 Study of MLN4924 (Pevonedistat) in Combination With Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated With Immunotherapy
-
CLINICAL_TRIALS study record update · 2023-11-21A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients: The NCI-NRG ALK Protocol
-
CLINICAL_TRIALS study record update · 2023-11-15Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): Physical Therapy and Progressive Muscle Relaxation in Improving Physical Performance and Mood in Older Patients With Stage IIIA-B or IV Lung Cancer Undergoing Treatment
-
CLINICAL_TRIALS study record update · 2023-10-30Prophylactic Tumor Treating Fields in Management of Patients With Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-10-26Embedded Palliative Care in the Management of Advanced Thoracic Malignancies
-
CLINICAL_TRIALS study record update · 2023-10-23Stress and Immunity in Lung Cancer Patients: Pilot Test of a Biobehavioral/Cognitive (ABC) Treatment for Stress, Depression, and Anxiety
-
CLINICAL_TRIALS study record update · 2023-10-18CASPIAN-RT Trial: Hypofractionated Consolidative Radiation Therapy After Durvalumab (MEDI4736) Plus Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-09-13A Phase II Study of Poziotinib and Ramucirumab in EGFR Exon 20 Mutant Advanced Non-small Cell Lung Cancer (NSCLC)
-
CLINICAL_TRIALS study record update · 2023-08-01A Single-Arm Phase 2 Study to Investigate Bintrafusp Alfa With Platinum-Pemetrexed for TKI-Resistant EGFR-Mutant NSCLC
-
CLINICAL_TRIALS study record update · 2023-06-01A Phase Ib/II, Open-Label, Multi-Center Study of EMB-01 in Combination With Osimertinib in Patients With Advanced/Metastatic EGFR Mutant Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-05-19Phase 1 Trial to Determine the Recommended Phase 2 Dose (RP2D) of M6620 (VX-970, Berzosertib) When Combined With Whole Brain Radiotherapy (WBRT) in Patients With Brain Metastases From Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-04-25A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
-
CLINICAL_TRIALS study record update · 2023-02-24Geriatric Assessment and Quality of Life in Older Adults Undergoing Definitive Treatment for Head and Neck or Lung Cancer and Their Informal Caregivers
-
CLINICAL_TRIALS study record update · 2023-02-16Bronchoscopic Laser Ablation of Solid Peripheral Lung Tumors Followed by Surgical Resection (BLAST-SR Trial)